Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Allegri

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Neurobiology of Aging|March 8, 2017
Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South AmericaEmilia M Gatto, Ricardo F Allegri, Gustavo Da Prat, et al.
Neuropsychiatric Disease and Treatment|October 4, 2016
Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer's Disease Neuroimaging InitiativeMaría Julieta Russo, Gabriela Cohen, Patricio Chrem Mendez, et al.
Revista De Neurologia|April 30, 2005
[Neuropsychological study of 12 patients with pure degenerative cerebellar disease]C G Abel, G Stein, S Pereyra, et al.
Vertex (Buenos Aires, Argentina)|August 11, 2012
[Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease]Ricardo F Allegri, María J Russo, Janus Kremer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 17, 2022
Changes in cognitive functioning after COVID-19: A systematic review and meta-analysisLucia Crivelli, Katie Palmer, Ismael Calandri, et al.
CNS Drugs|June 5, 2013
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitorsGeorge T Grossberg, Facundo Manes, Ricardo F Allegri, et al.
Applied Neuropsychology. Adult|March 6, 2024
Performance on the Latin American version of the Face-Name Associative Memory Exam (LAS-FNAME) distinguishes individuals with Mild Cognitive Impairment from age-matched controls in a sample from ArgentinaG Keller, N Corvalan, M A Carello, et al.
Neuropsychiatric Disease and Treatment|October 28, 2015
Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer's Disease Neuroimaging Initiative)Paula Harris, Marcos Fernandez Suarez, Ezequiel I Surace, et al.
Dementia & Neuropsychologia|December 8, 2017
A population-based study of cognitive impairment in socially vulnerable adults in Argentina. The Matanza Riachuelo study preliminary resultsLeonardo Bartoloni, Graciela Blatt, Iván Insua, et al.
Parkinsonism & Related Disorders|June 27, 2020
A novel mutation in PSEN1 (p.Arg41Ser) in an Argentinian woman with early onset ParkinsonismEmilia M Gatto, Galeno J Rojas, Sergio I Nemirovsky, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Neurobiology of Aging|March 8, 2017
Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South AmericaEmilia M Gatto, Ricardo F Allegri, Gustavo Da Prat, et al.
Neuropsychiatric Disease and Treatment|October 4, 2016
Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer's Disease Neuroimaging InitiativeMaría Julieta Russo, Gabriela Cohen, Patricio Chrem Mendez, et al.
Revista De Neurologia|April 30, 2005
[Neuropsychological study of 12 patients with pure degenerative cerebellar disease]C G Abel, G Stein, S Pereyra, et al.
Vertex (Buenos Aires, Argentina)|August 11, 2012
[Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease]Ricardo F Allegri, María J Russo, Janus Kremer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 17, 2022
Changes in cognitive functioning after COVID-19: A systematic review and meta-analysisLucia Crivelli, Katie Palmer, Ismael Calandri, et al.
CNS Drugs|June 5, 2013
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitorsGeorge T Grossberg, Facundo Manes, Ricardo F Allegri, et al.
Applied Neuropsychology. Adult|March 6, 2024
Performance on the Latin American version of the Face-Name Associative Memory Exam (LAS-FNAME) distinguishes individuals with Mild Cognitive Impairment from age-matched controls in a sample from ArgentinaG Keller, N Corvalan, M A Carello, et al.
Neuropsychiatric Disease and Treatment|October 28, 2015
Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer's Disease Neuroimaging Initiative)Paula Harris, Marcos Fernandez Suarez, Ezequiel I Surace, et al.
Dementia & Neuropsychologia|December 8, 2017
A population-based study of cognitive impairment in socially vulnerable adults in Argentina. The Matanza Riachuelo study preliminary resultsLeonardo Bartoloni, Graciela Blatt, Iván Insua, et al.
Parkinsonism & Related Disorders|June 27, 2020
A novel mutation in PSEN1 (p.Arg41Ser) in an Argentinian woman with early onset ParkinsonismEmilia M Gatto, Galeno J Rojas, Sergio I Nemirovsky, et al.
Pageof 19